1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
Species | Human |
Cat.No | ABC-TC3890 |
Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Product Category | Primary Cells |
Size/Quantity | 1 vial |
Cell Type | Mononuclear Cell |
Shipping Info | Dry Ice |
Growth Conditions | 37 ℃, 5% CO2 |
Source Organ | Peripheral Blood |
Disease | Mantle Cell Lymphoma |
Biosafety Level | 1 |
Storage | Liquid Nitrogen |
Product Type | Diseased Human Peripheral Blood Mononuclear Cells |
Human Mantle Cell Lymphoma Peripheral Blood Mononuclear Cells (Relapsed/Refractory) are derived from peripheral blood samples of patients with relapsed/refractory mantle cell lymphoma (MCL). Morphological analysis shows that this cell population mainly consists of atypical small lymphocytes, and its immunophenotype displays typical MCL features: Cyclin D1 and CD5 are diffusely and positively expressed, while SOX-11 is positive in some cases. The combination of these three markers provides a crucial basis for diagnosis.Its core genetic feature is the t(11;14)(q13;q32) chromosomal translocation, which leads to abnormal overexpression of the cyclin D1 (CCND1) gene, thereby driving the cell cycle out of control.Additionally, these cells exhibit persistent abnormal activation of the B cell receptor (BCR) signaling pathway, significantly enhancing tumor B cell survival by continuously activating downstream pathways such as PI3K/AKT and MAPK.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
Human Mantle Cell Lymphoma Peripheral Blood Mononuclear Cells (Relapsed/Refactory) can be used for high-throughput screening and efficacy verification of targeted drugs (such as BTK inhibitors, PI3K inhibitors), as well as sensitivity assessment of new immunotherapies (CAR-T, dual antibodies). In addition, these cells can also be used for drug resistance mechanism research and biomarker discovery to predict treatment response or relapse, including TP53 mutations and epigenetic changes.